Renhe Pharmacy Co.,Ltd (SHE:000650)

Market Cap	8.20B +7.4%
Revenue (ttm)	3.76B -13.9%
Net Income	445.37M +0.6%
EPS	0.32 +1.0%
Shares Out	1.38B
PE Ratio	18.55
Forward PE	n/a
Dividend	0.15 (2.56%)
Ex-Dividend Date	Jun 17, 2025

Volume	12,530,500
Average Volume	18,166,034
Open	5.83
Previous Close	5.92
Day's Range	5.83 - 5.98
52-Week Range	5.11 - 7.02
Beta	0.57
RSI	56.49
Earnings Date	Apr 24, 2026

About Renhe Pharmacy Co.,Ltd

Renhe Pharmacy Co.,Ltd produces and sells pharmaceutical products. It offers Chinese and western medicines and raw materials; and health-related products, including oral solid preparations and liquid preparations, large-volume and small-volume injections, external lotions, liniments, suppositories, ointments, and other dosage forms of drugs and health-related products. The company was founded in 1996 and is based in Nanchang, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 5,394
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000650

Financial Performance

In 2024, Renhe Pharmacy Co.,Ltd's revenue was 4.07 billion, a decrease of -19.02% compared to the previous year's 5.03 billion. Earnings were 481.91 million, a decrease of -15.05%.